Twist Bioscience Adds Invenra Bispecific Platform To Broaden Discovery Opportunity

Twist Bioscience (NasdaqGS:TWST) entered a licensing agreement with Invenra Inc. to co-exclusively provide Invenra's B-Body ...

Assessing Twist Bioscience (TWST) Valuation After Insider Sale And Recent Q1 FY26 Optimism

Twist Bioscience (TWST) stock came under pressure after Senior Vice President of Human Resources Paula Green sold more than 39,400 shares for nearly US$2.1 million, following a strong year to date ...
American Association of Individual Investors

Which Is a Better Investment, Celldex Therapeutics, Inc. or Twist Bioscience Corporation Stock?

Learn more about whether Celldex Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Business Wire

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Seeking Alpha

Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST) (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
Hosted on MSN

Twist Bioscience outlines 13–15.5% revenue growth target for 2026 as AI-driven orders accelerate

CEO Emily Leproust highlighted a record quarter with $99 million in revenue and 17% year-over-year growth, noting "our 11th quarter of consecutive growth." She stated, "For the year, we reported ...
Business Wire

Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...
Seeking Alpha

Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST) (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector ...
The Joplin Globe

Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has entered into a licensing agreement with Invenra Inc. (“Invenra”), a company that ...
Benzinga.com

Earnings Outlook For Twist Bioscience

Twist Bioscience (NASDAQ:TWST) is gearing up to announce its quarterly earnings on Monday, 2026-02-02. Here's a quick overview of what investors should know before the release. Analysts are estimating ...
Nasdaq

Twist Bioscience (TWST) Q3 Profit Surges

Twist Bioscience specializes in synthetic DNA production, providing gene fragments, next generation sequencing (NGS) tools, and antibody discovery platforms to research, diagnostic, pharmaceutical, ...